Standpoint Research Upgrades Teva Pharma (TEVA) to Buy
Go back to Standpoint Research Upgrades Teva Pharma (TEVA) to Buy| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 37.03 +0.57 (1.56%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.46 | 52 Week High | $66.55 | |||
| Open | $36.47 | 52 Week Low | $37.82 | |||
| Day High | $37.25 | P/E | N/A | |||
| Day Low | $36.34 | EPS | $0.00 | |||
| Volume | 3,055,887 | |||||
